The use of herbal therapy and aromatherapy is booming. Work is under way within the National Veterinary Medicine Agency (Anses-ANMV).

In this context and as part of the French Presidency of the Council of the European Union , Anses-ANMV has organised a European conference on the use of plants in veterinary medicine. This event has brought together representatives of breeders, veterinarians and industrialists, as well as the competent authorities, in particular the European Medicines Agency (EMA) and the European Commission.

European conference on the use of plants in veterinary medicine  - French Presidency of the Council of the European Union 2022 (europa.eu) - Paris on Thursday 29th March 2022

The conference was organised in several sessions. In the first session, the context of the use of plants in veterinary medicine in the European Union was presented and the various stakeholders (farmers, veterinarians and pharmaceutical industries) were able to share their expectations and problems with the use of veterinary herbal medicines. Secondly, two experts from the Human Committee on Herbal Medicinal Products presented a feedback on the problems encountered in the authorisation of herbal medicinal products for human use compared to conventional chemical medicinal products. Then, the Anses-ANMV gave a feedback on the work carried out by France, in particular on the referral 2014-SA-0083. Finally, these sessions continued with the presentation of the perspectives at European level by the EMA and the European Commission and the sharing of the views of the participants.

Conference overview

The network of Heads of Medicines Agencies (HMA) brings together all the agency directors responsible for medicines in the Member States of the European Union, the European Medicines Agency (EMA), the European Commission and the European Directorate for the Quality of Medicinal Products (EDQM).

This network allows the heads of agencies to exchange on issues related to the governance of medicinal products for human and veterinary use and to talk about health policy, both in human and animal health.

Two meetings of this network were organised by the French Presidency of the Council of the European Union in the first half of 2022: the first has been managed by the French Agency for the Safety of Medicines and Health Products (ANSM), the second by the French Agency for Food, Environmental and Labour Health Safety/French Agency for Veterinary Medicinal products (Anses-ANMV).

Meeting of Heads of Agency for Medicines (HMA 1 and 2) - French Presidency of the Council of the European Union 2022 (europa.eu) - Paris from Thursday 3rd to Friday 4th November 2022, Saint Malo from Wednesday 4th to Friday 6th May 2022

Post-meeting news of May 9th, 2022

The informal meeting of the Committee on Veterinary Medicinal Products (CVMP) and the Coordinating Group on Mutual and Decentralised Veterinary Recognition (CMDv) have brought together all the representatives of each Member State responsible for the evaluation of veterinary medicinal products. The European Medicines Agency (EMA) and the European Commission have also participated in this meeting.

This meeting has allowed committee members to exchange on dossiers related to the registration and evaluation of veterinary medicinal products in the European Union. It took place just four months after the entry into force of Regulation 2019/6 on veterinary medicinal products. The meeting of the two committees has therefore been an opportunity to continue to work on the implementation of this Regulation.

Informal meeting of the Committee for Veterinary Medicinal Products (CVMP — CMDv) - French Presidency of the Council of the European Union 2022 (europa.eu) - Saint Malo from Wednesday 30th May to Friday 1st June 2022